X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (167) 167
index medicus (98) 98
female (84) 84
male (82) 82
infectious diseases (79) 79
1-infected individuals (78) 78
immunology (70) 70
hiv infections - drug therapy (66) 66
adult (65) 65
hiv (62) 62
virology (59) 59
1-infected patients (58) 58
hiv infections - immunology (57) 57
hiv infections - virology (51) 51
viral load (44) 44
human-immunodeficiency-virus (40) 40
hiv-1 - genetics (37) 37
anti-hiv agents - therapeutic use (36) 36
hiv infection (36) 36
middle aged (34) 34
antiretroviral therapy (33) 33
health aspects (33) 33
hiv-1 (32) 32
hiv-1 - immunology (31) 31
infection (31) 31
aids (30) 30
human immunodeficiency virus--hiv (29) 29
viruses (29) 29
cd4 lymphocyte count (28) 28
disease progression (28) 28
child (27) 27
virus diseases (27) 27
active antiretroviral therapy (26) 26
antiretroviral therapy, highly active (26) 26
adolescent (25) 25
immunodeficiency-virus type-1 (25) 25
highly active antiretroviral therapy (24) 24
hiv-1 - drug effects (24) 24
research (24) 24
1-infected children (23) 23
microbiology (23) 23
research article (23) 23
antiviral agents (22) 22
pharmacology & pharmacy (22) 22
drug therapy (21) 21
cd4-positive t-lymphocytes - immunology (19) 19
hiv-1 infection (19) 19
infections (19) 19
therapy (19) 19
animals (18) 18
antiretroviral drugs (18) 18
t cells (18) 18
child, preschool (17) 17
drug resistance (17) 17
human immunodeficiency virus (17) 17
medicine (17) 17
risk factors (17) 17
acquired immune deficiency syndrome--aids (16) 16
flow cytometry (16) 16
infant (16) 16
lymphocytes (16) 16
multidisciplinary sciences (16) 16
treatment outcome (16) 16
cohort studies (15) 15
hiv-1-infected patients (15) 15
polymerase chain reaction (15) 15
aids/hiv (14) 14
molecular sequence data (14) 14
analysis (13) 13
care and treatment (13) 13
children (13) 13
genotype (13) 13
immune response (13) 13
science (13) 13
amino acid sequence (12) 12
article (12) 12
drug resistance, viral (12) 12
drug therapy, combination (12) 12
drug-resistance (12) 12
hiv infections - complications (12) 12
hiv-1 - physiology (12) 12
hiv-1-infected children (12) 12
individuals (12) 12
neutralization tests (12) 12
reverse transcriptase inhibitors - therapeutic use (12) 12
acquired immune deficiency syndrome (11) 11
aged (11) 11
anti-hiv agents - pharmacology (11) 11
anti-retroviral agents - therapeutic use (11) 11
antibodies (11) 11
cd8-positive t-lymphocytes - immunology (11) 11
cytokines (11) 11
hiv patients (11) 11
hiv-1 - pathogenicity (11) 11
hiv/aids (11) 11
in-vivo (11) 11
medicine, research & experimental (11) 11
mutations (11) 11
protease inhibitors (11) 11
replication (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2013, Volume 207, Issue 8, pp. 1216 - 1220
HIV-1 drug resistance represents a major obstacle to infection and disease control. This retrospective study analyzes trends and determinants of resistance in... 
HIV/AIDS | Antiretrovirals | HIV | Memory interference | Investigational drugs | Grants | Drug resistance | Genetic mutation | Genotypes | HIV 1 | Virology | HIV-1 | epidemiology | drug resistance | antiretroviral therapy | genotyping | INFECTIOUS DISEASES | MICROBIOLOGY | IMMUNOLOGY | 1-INFECTED PATIENTS | Multivariate Analysis | HIV-1 - pathogenicity | Prevalence | HIV Infections - epidemiology | Humans | Middle Aged | Reverse Transcriptase Inhibitors - pharmacology | Male | HIV Protease Inhibitors - pharmacology | Adult | Female | Retrospective Studies | Reverse Transcriptase Inhibitors - therapeutic use | Odds Ratio | pol Gene Products, Human Immunodeficiency Virus - genetics | Databases, Factual | Sexual Behavior | HIV-1 - drug effects | HIV Infections - virology | Risk Factors | Europe - epidemiology | pol Gene Products, Human Immunodeficiency Virus - analysis | Genotype | CD4 Lymphocyte Count | Drug Resistance, Multiple, Viral | HIV Protease Inhibitors - therapeutic use | HIV Infections - drug therapy | Mutation | Evolution, Molecular | Antiviral agents | Complications and side effects | Reports | Viral drug resistance | HIV infection | Distribution | Farmaceutiska vetenskaper | Immunologi inom det medicinska området | Klinisk medicin | Medicin och hälsovetenskap | Infektionsmedicin | Medicinska och farmaceutiska grundvetenskaper
Journal Article
AIDS Research and Human Retroviruses, ISSN 0889-2229, 10/2013, Volume 29, Issue 10, pp. 1321 - 1329
The potential role of conventional and regulatory T cells (Tregs) in protection from HIV-1 infection remains unclear. To address this question, we analyzed... 
Journal Article
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 17, pp. 2086 - 2095
Highlights • We used IgG1 and dimeric IgA2 versions of the V3-loop specific mAb HGN194. • HGN194 IgG1 given iv at a low dose to monkeys: 0% protection from... 
Allergy and Immunology | Rhesus monkey | IgA | 6 max | SHIV-C mucosal challenge | IgG | Complete protection | Passive immunization | VIRAL LOAD | MEDICINE, RESEARCH & EXPERIMENTAL | SHIV-C mucosal challenge (6 max) | PREVENTION | IMMUNOLOGY | AIDS VACCINE | 1-INFECTED INDIVIDUALS | IMMUNE-RESPONSES | HIV-1-INFECTED INDIVIDUALS | MACAQUES | INFECTION | MONOCLONAL-ANTIBODIES | VACCINE EFFICACY TRIAL | HIV Antibodies - blood | Antibodies, Neutralizing - administration & dosage | Immunoglobulin G - blood | Humans | Immunity, Mucosal | RNA, Viral - blood | Administration, Mucosal | Macaca mulatta | Immunoglobulin G - immunology | Antibodies, Monoclonal - immunology | Simian Immunodeficiency Virus - immunology | Simian Immunodeficiency Virus - pathogenicity | HIV Antibodies - administration & dosage | Immunoglobulin G - administration & dosage | Simian Acquired Immunodeficiency Syndrome - prevention & control | Administration, Intravenous | HIV-1 - immunology | Animals | Mucous Membrane - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Antibodies, Monoclonal - administration & dosage | Immunoglobulin A - immunology | Immunization, Passive | Immunoglobulin A - blood | T-Lymphocytes - immunology | Immunity, Cellular | Immunoglobulin A - administration & dosage | HIV (Viruses) | Immunoglobulin A | Immunoglobulin G | Medical research | Immunization | Vaccines | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0180245
Mechanisms responsible for natural control of human immunodeficiency type 1 (HIV) replication in elite controllers (EC) remain incompletely defined. To... 
DEPENDENT CELLULAR CYTOTOXICITY | VAGINAL SHIV CHALLENGE | 1-INFECTED INDIVIDUALS | INFECTED INDIVIDUALS | NEUTRALIZING ANTIBODY | IMMUNE-RESPONSES | MULTIDISCIPLINARY SCIENCES | NONNEUTRALIZING ANTIBODIES | CD4(+) T-CELLS | HUMAN-IMMUNODEFICIENCY-VIRUS | HELPER TYPE 17 | Enzyme-Linked Immunosorbent Assay | Immunoglobulin G - blood | HIV Envelope Protein gp41 - immunology | Humans | Middle Aged | Antibody Affinity | Male | Antiretroviral Therapy, Highly Active | HIV Infections - immunology | HIV Antibodies - biosynthesis | Immunoglobulin A - blood | Adult | Female | HIV Infections - drug therapy | HIV antigens | Antiviral agents | Development and progression | Dosage and administration | Research | HIV (Viruses) | Immunoglobulin A | Multiplexing | Controllers | Therapy | Peptides | Vaccines | Assaying | Antiinfectives and antibacterials | Epidemiology | Proteins | Highly active antiretroviral therapy | Human immunodeficiency virus--HIV | Intestinal microflora | Active control | Public health | Antigens | Antiretroviral drugs | Parasitology | Immunoglobulins | Immunodeficiency | Affinity | Avidity | Replication | Health sciences | Immunoglobulin G | Antibodies | Viruses | Infections | DNA-directed RNA polymerase | Western blotting | Heterogeneity | Immunology | E coli | Antiretroviral agents | Lymphocytes | Intestine | Race | Bacteria | Drug therapy | Enzyme-linked immunosorbent assay | Glycoprotein gp41 | Maturation | Nucleotide sequence | Neutrophils | Ribonucleic acid--RNA | Suppressors | Medicine | Polymerase | Glycoprotein gp160 | Lymphocytes B | Womens health | Hypergammaglobulinemia | RNA | Human immunodeficiency virus | Ribonucleic acid | HIV
Journal Article
12.